Manufacturing Archives - ISR Market Research

Marketing channels data for pharma service providers

By Brandon AllisonClinical Trials, Manufacturing

Support for marketing at pharma service providers Market research helps service providers to not only create relevant, focused content, but also make sure great content reaches their audiences in the ways they are most likely to engage. This is particularly...

Technologies & capabilities in demand for oral dosage forms manufacturing

By Jocelyn ReynoldsManufacturing

Outsourced manufacturing for oral dosage forms From the commonly available tablets and capsules to more specialized forms like bi-layer and chewables, oral dosage forms remain the most popular drug products on the market. In this highly competitive and flourishing landscape,...

Gene Therapy CDMO Timelines & Selection Attributes

By Brandon AllisonManufacturing

The Long Road to Approval for Gene Therapies We’ve come a long way from the first gene therapy clinical trial in 1990, but for all the hurdles overcome and advancements made, timelines remain one of the most prominent pain points...

How Do Outsourcers Feel About The CDMO Industry?

By Kate HammekeManufacturing

Industry Standard Research (ISR) regularly partners with The Rational Heart (TRH), a research organization focused on understanding how customers and prospects actually feel about their brand. ISR conducts this type of study for our clinical research and contract manufacturing clients...

Exploring the Integral Role of CMC in Small and Emerging Biopharma

By Laura McWhinneyManufacturing

The Chemistry, Manufacturing, and Controls Function In the dynamic world of biopharmaceuticals, small and emerging companies play a vital role in driving innovation and advancing groundbreaking therapies. While these companies often possess cutting-edge science and promising drug candidates, they may...

Biopharma Outsourcing Trends for Sterile Injectable Manufacturing

By Brandon AllisonManufacturing

Evolving Perceptions and Practices in Sterile Injectable Outsourcing Sterile injectable medicines provide significant advantages in terms of rapid and accurate drug delivery. Many newer medications cannot be produced as an oral dosage form for various reasons, making injectable delivery an...

Which CDMO Traits Predict Sponsor Loyalty When Outsourcing Small Molecule API?

By Kate HammekeManufacturing

Industry Standard Research’s CDMO Benchmarking reports include loyalty scores for each of the service providers included in the research. ISR computes loyalty as an index that consists of overall satisfaction, willingness to recommend, and likelihood to use again. The loyalty...

Cell & Gene Therapies Outsourcing Trends

By Brandon AllisonManufacturing

The Growing Cell & Gene Market The outsourced cell and gene manufacturing space has experienced notable expansion and change in recent years. As the advancement of cell and gene therapies continues, drug innovator companies have come to rely heavily on...

Performance Benchmarking Informs Service Provider Selection

By ISR ReportsClinical Trials, Manufacturing

Selecting a CMO or CRO is stressful, expensive, and time-consuming. The complexity of these supplier organizations makes them difficult to evaluate. Far too often, decision makers lack vital information to support selection decisions. But the consequences of selecting the wrong...

COVID Continues to Impact Outsourced Manufacturing and Supply Chain Security

By Kate HammekeManufacturing

Each of the past three years, Industry Standard Research has included questions in its annual CDMO benchmarking research to better understand whether the pandemic has affected drug innovators’ outsourced manufacturing for small molecule drug substance, small molecule drug product, biologic...

CDMO Performance on Service Provider Selection Criteria

By Laura McWhinneyManufacturing

2023 is the 12th year of Life Science Leader’s annual CDMO Leadership Awards, where contract manufacturers are recognized for their ability to deliver above and beyond the expectations of their drug innovator clients. The awards are the result of sponsor...

Industry Trends: Clinical Trial Logistics Outsourcing

By Tim EggertManufacturing, Supply Chain & Logistics

Clinical Trial Logistics Market Dynamics Clinical trials often span numerous sites around the globe and continue to implement more and more decentralized elements, such as in-home visits by healthcare providers. Accordingly, the storage and distribution of clinical trial material has...

Tracking the Evolution of CDMO Selection Criteria for Biologic Drug Substance Manufacturing

By Jenn HollowayManufacturing

Biologic drug substance developers face an ever-evolving slate of challenges related to CDMO outsourcing. As part of ISR’s CDMO Benchmarking research, respondents are asked to review a list of 28 selection attributes and to identify the one criterion most important...

The Value of Strategic Outsourcing Relationships

By Kate HammekeManufacturing, Supply Chain & Logistics

The Evolution of Outsourcing Over the past few decades there have been considerable changes in the outsourcing environment; at the outset, pharmaceutical companies were primarily offshoring to lower-cost centers and used different contract manufacturers for different projects in a somewhat...

How Industry Benchmarks Can Inform CDMO Selection

By Laura McWhinneyManufacturing

Biopharmaceutical sponsor considerations when selecting a CDMO may include timelines, cost, regulatory requirements, capacity, quality, risks, and previous experience. To help sponsors better understand and prioritize development and manufacturing elements, ISR conducts four annual, manufacturing-specific benchmark studies that ask professionals...

Five Steps to CDMO Selection

By Brandon AllisonManufacturing

Sponsors will see success in their CDMO partnerships by dedicating time and effort to establish a plan that identifies outsourcing drivers, to select a model that matches company needs and resources, to establish a decision-making process and group, and to...

Highly Potent API Manufacturing

By Brandon AllisonManufacturing

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…

Commercial Bioprocessing Market Outlook

By Brandon AllisonManufacturing

Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…

Cell & Gene Market Outlook

By Brandon AllisonManufacturing

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…